• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The immunomodulating roles of glycoproteins in epithelial ovarian cancer.糖蛋白在上皮性卵巢癌中的免疫调节作用。
Front Biosci (Elite Ed). 2012 Jan 1;4(2):631-50. doi: 10.2741/405.
2
Ovarian cancer and the immune system - The role of targeted therapies.卵巢癌与免疫系统——靶向治疗的作用
Gynecol Oncol. 2016 Aug;142(2):349-56. doi: 10.1016/j.ygyno.2016.05.007. Epub 2016 May 23.
3
Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer.人上皮性卵巢癌的免疫:癌症中免疫抑制的范例。
J Transl Med. 2013 Jun 13;11:147. doi: 10.1186/1479-5876-11-147.
4
Immune response evaluation through determination of type 1, type 2, and type 17 patterns in patients with epithelial ovarian cancer.通过确定 1 型、2 型和 17 型模式评估上皮性卵巢癌患者的免疫反应。
Reprod Sci. 2013 Jul;20(7):828-37. doi: 10.1177/1933719112466299. Epub 2012 Dec 13.
5
MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells.MUC16 通过抑制 NK 和卵巢癌细胞之间的突触形成提供免疫保护。
Mol Cancer. 2010 Jan 20;9:11. doi: 10.1186/1476-4598-9-11.
6
Serological and immunochemical analysis of Lewis y (Ley) blood group antigen expression in epithelial ovarian cancer.上皮性卵巢癌中Lewis y(Ley)血型抗原表达的血清学和免疫化学分析
Int J Cancer. 1996 Feb 8;65(4):406-12. doi: 10.1002/(SICI)1097-0215(19960208)65:4<406::AID-IJC2>3.0.CO;2-0.
7
Role of TIM-3 in ovarian cancer.TIM-3 在卵巢癌中的作用。
Clin Transl Oncol. 2017 Sep;19(9):1079-1083. doi: 10.1007/s12094-017-1656-8. Epub 2017 Mar 29.
8
Purified autoantibodies against glucose-regulated protein 78 (GRP78) promote apoptosis and decrease invasiveness of ovarian cancer cells.纯化的葡萄糖调节蛋白 78(GRP78)自身抗体促进卵巢癌细胞凋亡和侵袭力下降。
Cancer Lett. 2011 Oct 1;309(1):104-9. doi: 10.1016/j.canlet.2011.05.022. Epub 2011 Jun 11.
9
Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer.调节性T细胞、遗传变异与上皮性卵巢癌的临床结局
Cancer Immunol Immunother. 2015 Dec;64(12):1495-504. doi: 10.1007/s00262-015-1753-x. Epub 2015 Aug 23.
10
Peritoneal immune system in patients with advance epithelial ovarian cancer.晚期上皮性卵巢癌患者的腹膜免疫系统。
Int Rev Immunol. 2011 Apr-Jun;30(2-3):87-101. doi: 10.3109/08830185.2011.569902.

引用本文的文献

1
Influence of the glycocalyx on the size and mechanical properties of plasma membrane-derived vesicles.糖萼对质膜衍生囊泡大小和力学性质的影响。
Soft Matter. 2025 Jan 15;21(3):463-475. doi: 10.1039/d4sm01317d.
2
Limitations and potential of immunotherapy in ovarian cancer.免疫疗法在卵巢癌中的局限性和潜力。
Front Immunol. 2024 Jan 9;14:1292166. doi: 10.3389/fimmu.2023.1292166. eCollection 2023.
3
The mucin MUC16 (CA125) binds to NK cells and monocytes from peripheral blood of women with healthy pregnancy and preeclampsia.黏蛋白 MUC16(CA125)与健康妊娠和子痫前期妇女外周血中的 NK 细胞和单核细胞结合。
Am J Reprod Immunol. 2012 Jul;68(1):28-37. doi: 10.1111/j.1600-0897.2012.01113.x. Epub 2012 Mar 1.

本文引用的文献

1
Novel glycosaminoglycan biosynthetic inhibitors affect tumor-associated angiogenesis.新型糖胺聚糖生物合成抑制剂影响肿瘤相关血管生成。
Biochem Biophys Res Commun. 2011 Jan 7;404(1):86-9. doi: 10.1016/j.bbrc.2010.11.069. Epub 2010 Nov 19.
2
[Functional roles of glycans for interaction between cytokines and receptors].[聚糖在细胞因子与受体相互作用中的功能作用]
Tanpakushitsu Kakusan Koso. 2008 Sep;53(12 Suppl):1513-9.
3
Molecular markers in epithelial ovarian cancer: their role in prognosis and therapy.上皮性卵巢癌中的分子标志物:它们在预后和治疗中的作用。
Eur J Gynaecol Oncol. 2010;31(3):268-77.
4
N-Glycosylation of total cellular glycoproteins from the human ovarian carcinoma SKOV3 cell line and of recombinantly expressed human erythropoietin.人卵巢癌细胞系 SKOV3 总细胞糖蛋白和重组人红细胞生成素的 N-糖基化。
Glycobiology. 2011 Mar;21(3):376-86. doi: 10.1093/glycob/cwq170. Epub 2010 Oct 28.
5
Sialylation of 3-methylcholanthrene-induced fibrosarcoma determines antitumor immune responses during immunoediting.3-甲基胆蒽诱导的纤维肉瘤的唾液酸化决定了免疫编辑过程中的抗肿瘤免疫反应。
J Immunol. 2010 Nov 15;185(10):5869-78. doi: 10.4049/jimmunol.1001635. Epub 2010 Oct 18.
6
CA125 immune complexes in ovarian cancer patients with low CA125 concentrations.卵巢癌患者中 CA125 浓度低时的 CA125 免疫复合物。
Clin Chem. 2010 Dec;56(12):1889-92. doi: 10.1373/clinchem.2010.153122. Epub 2010 Oct 13.
7
Lectin-based glycoproteomic techniques for the enrichment and identification of potential biomarkers.基于凝集素的糖蛋白质组学技术用于富集和鉴定潜在生物标志物。
Methods Enzymol. 2010;480:461-76. doi: 10.1016/S0076-6879(10)80020-5.
8
Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant.基于糖基化 Tn 的疫苗靶向真皮树突状细胞,在没有佐剂的情况下有利于生发中心 B 细胞的发育和产生有效的抗体反应。
Blood. 2010 Nov 4;116(18):3526-36. doi: 10.1182/blood-2010-04-279133. Epub 2010 Aug 18.
9
Glycodelin A suppresses the cytolytic activity of CD8+ T lymphocytes.糖蛋白 130 抑制 CD8+T 淋巴细胞的细胞溶解活性。
Mol Immunol. 2010 Sep;47(15):2458-66. doi: 10.1016/j.molimm.2010.06.008. Epub 2010 Jul 17.
10
Chemical Tumor Biology of Heparan Sulfate Proteoglycans.硫酸乙酰肝素蛋白聚糖的化学肿瘤生物学
Curr Chem Biol. 2010 Jan 1;4(1):20-31. doi: 10.2174/187231310790226206.

糖蛋白在上皮性卵巢癌中的免疫调节作用。

The immunomodulating roles of glycoproteins in epithelial ovarian cancer.

作者信息

Patankar Manish S, Gubbels Jennifer A A, Felder Mildred, Connor Joseph P

机构信息

Department of Obstetrics and Gynecology, University of Wisconsin-Madison, WI 53792-6188, USA.

出版信息

Front Biosci (Elite Ed). 2012 Jan 1;4(2):631-50. doi: 10.2741/405.

DOI:10.2741/405
PMID:22201900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4326102/
Abstract

The complexity of the immune system demands an intricate defense mechanism by tumors. Ovarian and other tumors employ specific glycoproteins and the associated glycan sequences to modulate immune responses. Glycoproteins enable tumor cells that express or secrete these molecules to evade immune cell attack and induce the immune system to promote tumor growth. This review focuses first on the immune environment in ovarian cancer, and the mechanisms of activation and inhibition that immune cells undergo in order to either attack or ignore a target cell. Next we illustrate the immunomodulatory roles of ovarian cancer-associated glycans and glycoproteins in 1. preventing immune synapse formation, 2. serving as ligands of immune cell receptors, 3. scavenging cytokines and chemokines, and 4. participating in the formation of autoantibodies against the tumor. The importance of these immunomodulating strategies from the view points of understanding the tumor immunology of ovarian tumors, potential origin of such mechanisms, and specific strategies to circumvent the glycoconjugate-mediated suppression of immune responses is discussed in this review.

摘要

免疫系统的复杂性要求肿瘤具备复杂的防御机制。卵巢癌及其他肿瘤利用特定的糖蛋白及相关聚糖序列来调节免疫反应。糖蛋白使表达或分泌这些分子的肿瘤细胞能够逃避免疫细胞的攻击,并诱导免疫系统促进肿瘤生长。本综述首先聚焦于卵巢癌中的免疫环境,以及免疫细胞为攻击或忽略靶细胞而经历的激活和抑制机制。接下来,我们阐述卵巢癌相关聚糖和糖蛋白在以下方面的免疫调节作用:1. 阻止免疫突触形成;2. 作为免疫细胞受体的配体;3. 清除细胞因子和趋化因子;4. 参与针对肿瘤的自身抗体形成。本综述从理解卵巢肿瘤的肿瘤免疫学、此类机制的潜在起源以及规避糖缀合物介导的免疫反应抑制的具体策略等角度,探讨了这些免疫调节策略的重要性。